166 related articles for article (PubMed ID: 34920977)
1. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group.
Bjerklund Johansen TE; Kulchavenya E; Lentz GM; Livermore DM; Nickel JC; Zhanel G; Bonkat G
Eur Urol Focus; 2022 Sep; 8(5):1483-1492. PubMed ID: 34920977
[TBL] [Abstract][Full Text] [Related]
2. [Optimization of prevention of infectious complications during prostate biopsy].
Kolontarev K B; Stroganov R V; Pushkar D Y
Urologiia; 2023 Dec; (6):128-132. PubMed ID: 38156696
[TBL] [Abstract][Full Text] [Related]
3. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy.
Krsakova E; Cermak A; Fedorko M
J Hosp Infect; 2024 Mar; 145():83-87. PubMed ID: 38219833
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
[TBL] [Abstract][Full Text] [Related]
7. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study.
Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H
Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009
[TBL] [Abstract][Full Text] [Related]
10. Rediscovering the value of fosfomycin trometamol in the era of antimicrobial resistance: A systematic review and expert opinion.
Cai T; Novelli A; Tascini C; Stefani S
Int J Antimicrob Agents; 2023 Dec; 62(6):106983. PubMed ID: 37748624
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
[TBL] [Abstract][Full Text] [Related]
12. [Prostate biopsy 2021: current management].
Wagenlehner F; Bonkat G; Pilatz A
Aktuelle Urol; 2021 Aug; 52(4):356-359. PubMed ID: 33979884
[TBL] [Abstract][Full Text] [Related]
13. [Infectious complications following prostate biopsy-Major changes 2020].
Pilatz A; Bonkat G; Wagenlehner F
Urologe A; 2020 Dec; 59(12):1486-1491. PubMed ID: 33044635
[TBL] [Abstract][Full Text] [Related]
14. Comment to: "Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin".
Jiménez-Pacheco A
Actas Urol Esp; 2015 Apr; 39(3):137-8. PubMed ID: 25443521
[No Abstract] [Full Text] [Related]
15. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
[TBL] [Abstract][Full Text] [Related]
16. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study.
Yu SH; Jung SI; Ryu JW; Kim MS; Chung HS; Hwang EC; Kwon DD
Investig Clin Urol; 2022 Nov; 63(6):663-670. PubMed ID: 36347556
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis.
Pilatz A; Dimitropoulos K; Veeratterapillay R; Yuan Y; Omar MI; MacLennan S; Cai T; Bruyère F; Bartoletti R; Köves B; Wagenlehner F; Bonkat G; Pradere B
J Urol; 2020 Aug; 204(2):224-230. PubMed ID: 32105195
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
Bovo A; Kwiatkowski M; Manka L; Wetterauer C; Fux CA; Cattaneo M; Wyler SF; Prause L
World J Urol; 2024 May; 42(1):356. PubMed ID: 38806739
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: Results from a large Canadian cohort.
Carignan A; Sabbagh R; Masse V; Gagnon N; Montpetit LP; Smith MA; Raymond M; Allard C; Bergeron C; Pépin J
J Glob Antimicrob Resist; 2019 Jun; 17():112-116. PubMed ID: 30553114
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Two Fosfomycin Regimens as Antimicrobial Prophylaxis for Transrectal Prostate Biopsy: A Randomised Study.
D'Elia C; Mian C; Hanspeter E; Ladurner C; Palermo SM; Pycha S; Saleh O; Cai T; Spoladore G; Kafka M; Pycha A; Trenti E
Urol Int; 2019; 103(4):433-438. PubMed ID: 31614361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
